Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); irAE; immune related adverse event; ECOG PS; European cooperative oncology group performance status; n.s.; not significant; EGFR; epidermal growth factor receptor; ALK; anaplastic lymphoma kinase; PD-L1; programmed death-ligand 1; TKI; tyrosine-kinase inh
مقالات ISI سرطان ریه غیر سلولی کوچک (NSCLC) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); PD-1; programed cell death-1; PD-L1; programmed cell death ligand 1; NSCLC; non-small-cell lung cancer; OS; overall survival; PFS; progression-free survival; ORR; objective response rate; irAEs; immune-related adverse events; RECIST; response evaluation c
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Independent validation; Non-small-cell lung cancer (NSCLC); Performance status; Prognostic models;
Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); lncRNA XIST; Non-small-cell lung cancer (NSCLC); miR-141; Transforming growth factor beta (TGF-β); EMT;
Original articleOver-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); CircRNA_100876; Non-small-cell lung cancer (NSCLC); Biomarker; Prognosis;
EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Human immunodeficiency virus (HIV); Non-small-cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR) mutation; Kirsten Ras (KRAS) mutation;
Analysis of the relationship between lung cancer drug response level and atom connectivity dynamics based on trimmed Delaunay triangulation
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Epidermal growth factor receptor (EGFR); Non-small-cell lung cancer (NSCLC); Molecular dynamics (MD) simulations; Drug response level; Three-dimensional Delaunay triangulation;
AKT inactivation causes persistent drug tolerance to EGFR inhibitors
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); SCLC; small cell lung cancer; NSCLC; non-small-cell lung cancer; TKIs; tyrosine kinase inhibitors; RTK; receptor tyrosine kinase; EGFR; epidermal growth factor receptor; IGF-1R; insulin-like growth factor 1 receptor; FGFR1; fibroblast growth factor recept
We're in this together: Patients', caregivers' and health care providers' illness perceptions about non-small-cell lung cancer (NSCLC)
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Non-small-cell lung cancer (NSCLC); Illness perceptions; Caregivers; Health care providers; Psychosocial research; Literature review;
Nouvelle perspective de traitement dans le cancer bronchique non à petites cellules (CBNPC). Place de l'afatinib : un inhibiteur oral et irréversible de la famille ErbB
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); cancer bronchique non à petites cellules (CBNPC); facteur de croissance épidermique (EGF); récepteur de l'EGF; inhibiteur de tyrosine kinase (ITK); afatinib; non-small-cell lung cancer (NSCLC); epidermal growth factor (EGF); EGF-receptor; tyrosine ki
SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); iTRAQ; SWATH™; Non-small-cell lung cancer (NSCLC); Secretome; Metastasis; CD109
KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); KRAS mutations; EGFR-targeted therapy; Colorectal cancer (CRC); Non-small-cell lung cancer (NSCLC); Predictive biomarkers; Personalized medicine; Molecular genetics;
A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Epidermal growth factor receptor (EGFR) mutations; Erlotinib; First line; Japanese patients; Non-small-cell lung cancer (NSCLC); Phase II; EGFR testing;
Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Combination therapy; Epidermal growth factor receptor (EGFR); EGFR mutation; Non-small-cell lung cancer (NSCLC); Tyrosine kinase inhibitor (TKI);
Influencia pronóstica de la pérdida de la expresión del antÃgeno del grupo sanguÃneo A en el carcinoma no microcÃtico de pulmón en estadio I patológico
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); AntÃgeno del grupo sanguÃneo A (GSA); Adenocarcinoma de pulmón; Carcinoma no microcÃtico de pulmón (CNMP); Estadio patológico; Factores pronósticos; Blood group antigen A (BAA); Lung adenocarcinoma; Non-small-cell lung cancer (NSCLC); Pathologic st
Prognostic Influence of Loss of Blood Group A Antigen Expression in Pathologic Stage I Non-Small-Cell Lung Cancer
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Blood group antigen A (BAA); Lung adenocarcinoma; Non-small-cell lung cancer (NSCLC); Pathologic stage; Prognostic factorsAntígeno del grupo sanguíneo A (GSA); Adenocarcinoma de pulmón; Carcinoma no microcítico de pulmón (CNMP); Estadio patológico; Factor
First-line Systemic Therapy for Metastatic Non-small-cell Lung Cancer - A Review
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); chemotherapy; non-small-cell lung cancer (NSCLC); targeted therapy;
Effect of gefitinib challenge to initial treatment with non-small cell lung cancer
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Gefitinib; Non-small-cell lung cancer (NSCLC); First-line treatment
Effect of CYP1A1 MSPI Polymorphism on the Relationship Between TP53 Mutation and CDKN2A Hypermethylation in Non-small Cell Lung Cancer
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Non-small-cell lung cancer (NSCLC); CYP1A1; GSTM1; Polymorphism; TP53 mutation; CDKN2A methylation
Impact of Incidental Irradiation on Clinically Uninvolved Nodal Regions in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Involved-Field Radiation Therapy: Does Incidental Irradiation Contribute to the Low Incidence of Elective Nodal Failu
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Involved-field radiation therapy (IF-RT); Elective nodal failure (ENF); Incidental irradiation; Non-small-cell lung cancer (NSCLC);
Safety and feasibility of radiotherapy treatment in elderly non-small-cell lung cancer (NSCLC) patients
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Elderly patients; Lung cancer; Radiotherapy of lung cancer; Non-small-cell lung cancer (NSCLC)
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Non-small-cell lung cancer (NSCLC); Reversion-inducing cysteine-rich protein with Kazal motifs (RECK); Matrix metalloproteinase (MMP); Quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR); Surgery; Prognosis
Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancer
Keywords: سرطان ریه غیر سلولی کوچک (NSCLC); Non-small-cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR); EGFR tyrosine kinase inhibitor; Gefitinib; 'Iressa';